Catalyst
Slingshot members are tracking this event:
Acadia Pharmaceuticals - primary endpoint not met in ACP-044 phase 2 trial for acute pain following bunionectomy surgery
- Source Link:
- https://thefly.com/n.php?id=3495267
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ACAD |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 18, 2022
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Acute Pain, Bunionectomy Surgery, Acp-044
